Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazarotene cream dose-finding in lamellar ichthyosis
2006-006878-22Phase 2Completed
- Sponsor
- Orphagen Therapeutics
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tazarotene in lamellar ichthyosis (LI) (2 arms), sponsored by Orphagen Therapeutics. Primary endpoint: Investigator assessment of scaling and roughness. Started Aug 2007; status: completed.
02
Drugs
tazarotene
03
Conditions
lamellar ichthyosis (LI)
Beyond the preview
Go deeper on 2006-006878-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006878-22.